Summary
Five patients, three males and two females, with angioimmunoblastic lymphadenopathy (AIL) are described. The two who received steroids had no response and died 2 and 6 months later. The three patients who received vincristine, adriamycin and prednisolone (VAP) went into remission early and are still in remission with a follow-up of 22–35 months. It is concluded that VAP is effective therapy in AIL.
References
Case records of the Massachusetts General Hospital (1980) Case 11. N Engl J Med 302: 678–684
Cullen MN, Stansfeld AG, Oliver RTD, Lister TA, Malpas JS (1979) Angioimmunoblastic lymphadenopathy: Report of ten cases and review of the literature. Q J Med 44: 171–182
Frizzera G, Moran EM, Rappaport H (1975) Angioimmunoblastic lymphadenopathy: Diagnosis and clinical course. Am J Med 59: 803–818
Kaneko Y, Larson RA, Variakojis D, Haren JM, Rowley JD (1982) Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy. Blood 60: 877–887
Lukes RJ, Tindle BH (1975) Immunoblastic lymphadenopathy: A hyperimmune entity resembling Hodgkin's disease. N Engl J Med 292: 1–8
Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H (1978) Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer 41:578–606
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Awidi, A.S., Tarawneh, M.S., Abu Khalaf, M.S. et al. Therapeutic effect of vincristine, adriamycin and prednisolone (VAP) in angioimmunoblastic lymphadenopathy (AIL). Cancer Chemother. Pharmacol. 10, 221–222 (1983). https://doi.org/10.1007/BF00255768
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00255768